Form EFFECT NeuroSense Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 12, 2024 5:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The First 90 Days After Closing Are When Most Home Systems Break. Here’s What Buyers Don’t Know.
- Kaufman & Company Expands BridgeStar.ai Into a Full Partner Portal, Adding Eight New Engagement Tracks and a Suite of Client Tools
- SATO Technologies Corp. Announces Loan Settlement Eliminating All of Its Senior Secured Debt and C$1.5 Million Private Placement
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
